Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV): Phase - Freebase

Share This

Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

The purpose of this study determine whether the drug valganciclovir has a significant and real benefit on the central core of symptoms experienced by patients who have high titers to EBV and HHV-6 and are experiencing long-standing fatigue and cognitive impairment (CFS). In addition, to characterize...

Learn more about Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV) »

Add More Topics

2 Medical trial phase topics matching:

Filter this Collection

x Phase name is Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
x



and...

All topics Only topics with images

+

x Add new column Show in info bubble Show in info bubble Add new edge

Medical trial phase
Other Columns Other Info
- Also known as
- » article
- » image
- » Subjects
- » Subject of
- » Also Typed With
- name
- Creation Date
- » creator

more

I

II

Edit Collection Schema

All topics in this collection are typed as Medical trial phase

Use Data from this Collection

Choose a format:

Images and articles are not included in export files, which are limited to 1000 items. Complete data dumps are also available here.

Flag this Collection

Why do you want to flag this collection?

Label as possibly offensive